Pregnancy and Fibrin Clot Properties
NCT07275476 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-12-10
Summary
1. The structure of fibrin clot and thrombin generation may vary between trimesters of pregnancy.
2. Unfavorably altered fibrin clot properties along with enhanced thrombin generation may lead to the development of complications during pregnancy such as TE and hypertensive disorders.
3. The application of machine learning techniques may help to identify previously undetected phenotypes with increased risk of TE and hypertensive disorders during pregnancy.
Conditions
- Fibrin Blood Clot
- Pregnancy
- Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode
Interventions
- DIAGNOSTIC_TEST
-
analysis of fibrin clot properties and thrombin generation
determination of fibrin clot properties and thrombin generation
Sponsors & Collaborators
-
Jagiellonian University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-11-28
- Primary Completion
- 2026-01-31
- Completion
- 2027-12-31
Countries
- Poland
Study Locations
More Related Trials
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Thrombophilia Screening After Severe IUGR
NCT05551078 ·Status: UNKNOWN
-
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691 ·Status: TERMINATED ·Phase: NA
-
EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
NCT02407730 ·Status: COMPLETED
-
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
NCT02507180 ·Status: UNKNOWN
-
Evaluation of the Quantra QStat System in Obstetric Patients
NCT05875987 ·Status: COMPLETED
-
Evaluation of Novel Point of Care Coagulation System in Pregnant Women
NCT04301193 ·Status: COMPLETED
-
Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage
NCT02149472 ·Status: COMPLETED
-
Bedside Assessment of Coagulation in Post-partum Hemorrhage by Thromboelastography (TEG ®6S)
NCT03592303 ·Status: UNKNOWN
-
Left Rule, D-Dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy.
NCT01708239 ·Status: UNKNOWN
-
QStat Cartridge in Obstetric Patients
NCT06255496 ·Status: COMPLETED
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Concordance Between the Measurement of Whole Blood Fibrinogen by the qLabs®FIB Analyzer and Its Measurement by Conventional Method (Clauss Fibrinogen) in the Context of Severe Postpartum Haemorrhage
NCT06255002 ·Status: RECRUITING
-
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
NCT01359878 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pregnancy and Risk of Venous Thromboembolism
NCT03659708 ·Status: RECRUITING ·Phase: NA
-
Venous Thromboembolism in Pregnancy Study
NCT00856076 ·Status: UNKNOWN
-
Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis
NCT02130648 ·Status: UNKNOWN
-
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
NCT05739097 ·Status: UNKNOWN
-
A Study of Pregnancy Outcomes in Congenital Heart Disease
NCT06678256 ·Status: WITHDRAWN
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Study of the Platelet Function During the Last Month of Pregnancy
NCT02828852 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth in Women Presenting With Signs and Symptoms of Preterm Labor
NCT05742997 ·Status: UNKNOWN ·Phase: NA
-
Thromboelastogram in Postdelivery Preeclamptic Patients
NCT03555630 ·Status: COMPLETED
-
Innovations in Placental Metabolism and Association With Antioxidants and Nutrients in Diabetes and Gestational Obesity
NCT05174728 ·Status: SUSPENDED
-
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 ·Status: RECRUITING ·Phase: NA